autologous natural killer cell therapy (Jilin Provincial Qijian Biology Technology)

N/A

Report date: 2025/03/14 16:35:46

Base Information

Drug Nameautologous natural killer cell therapy (Jilin Provincial Qijian Biology Technology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > Natural killer cell therapy
Mechanisms of ActionImmunomodulatorsNatural killer cells modulators
TargetsUpdating
Therapy Area/IndicationsGastrointestinal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJilin Qijian Bio-Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJilin Qijian Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsGastrointestinal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A